Friday, November 22, 2024

Novo Nordisk Says Ozempic Drug Cuts Risk of Kidney Problems

Must read

[ad_1]


Novo Nordisk’s blockbuster weight-loss drug cuts the risk of kidney disease-related events in diabetic patients by 24%, according to a new clinical trial conducted by the company.

[ad_2]

Source link

spot_img
spot_img

Latest article